SGLT2 Inhibition. Changing what fuels the heart
Lehrke M
JACC. 2019;73(15):1945-7
Leggi
A turning point for chronic kidney disease in diabetes
Tuttle KR
The Lancet. Pub. online 14 April 2019
Leggi
Campagna raccolta fondi 5 x mille Fondazione AMD
Caro Socio, in occasione del lancio della prossima Campagna raccolta fondi 5 x mille, siamo lieti di poterti aggiornare sulle attività in corso, e programmate, della Fondazione AMD. Il 5 x mille rappresenta per Fondazione AMD la possibilità di finanziamenti trasparenti che permettono a tutti noi di portare avanti iniziative…
Leggi
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
Pollock C, Stefánsson B, Reyner D, et al.
The Lancet Diabetes & Endocrinology. Pub. online 13 April 2019
Leggi
Bando di concorso per la partecipazione di Soci AMD al DIP 2019
The 10th International Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy E’ stato pubblicato il bando di concorso per la partecipazione al DIP Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy 2019 che si terrà a Firenze dal 29 maggio al 1° giugno pp.vv. Il termine ultimo per la…
Leggi
SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease
Tuttle KR
The Lancet Diabetes & Endocrinology. Pub. online 13 April 2019
Leggi
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
Perkovic V, Jardine MJ, Neal B, et al. for the CREDENCE Trial Investigators
NEJM. Pub. Online 14 April 2019
Leggi
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
Musso G, Gambino R, Cassader M, Paschetta E
BMJ. 2019;365:l1328
Leggi
Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation
Blair JC, McKay A, Ridyard C, et al.
BMJ. 2019;365:l1226
Leggi
Retinal nonperfusion characteristics on ultra-widefield angiography in eyes with severe nonproliferative diabetic retinopathy and proliferative diabetic retinopathy
Nicholson L, Ramu J, Chan EW, et al.
JAMA Ophthalmol. Published online, 11 April 2019.
Leggi